Knockout mice are the gold standard to probe for the role of a specific protease within the interacting network of proteases, substrates, and inhibitors. This proteolytic network, or protease web, determines cell signaling and organ homeostasis. Therefore, protease deficiency or inhibition is intrinsically tied to alterations within this network, always leading to new molecular phenotypes, which define susceptibility of an organ to disease. Furthermore, recent hints, mainly from research on matrix metalloproteinases, about the impact of the protease web on inter-organ signaling molecules suggest the existence of a proteolytic internet of communicating local organ-or molecular polymorphism-specific networks, thereby defining homeostasis and disease susceptibility in the whole organism.
Introduction
Functional genetic mouse models with specific overexpression or total lack of expression of genes have contributed to elucidation of their physiological functions as well as the pathological consequences induced by their deregulated expression (Bolon and Galbreath, 2002) , and are the basis of many mouse carcinogenesis models under study (Frese and Tuveson, 2007) . The branch of cancer research, however, which does not focus on tumorigenesis, but on unsolved problems of tumor cell dissemination and metastasis, is not as dependent on genetically engineered mice with an overt functional or structural phenotype: genetic modulation of the host tissue is already a sufficient experimental manipulation, as it is now recognized that the microenvironment is an important determinant in tumor progression and metastasis (Kulesa et al., 2006) . Evidence is increasing that the primary tumor together with the target organ of metastasis, and the bone marrow as a metastasis-promoting distant compartment, altogether form the crucial triad that determines metastatic efficacy (Gupta and Massagué , 2006) . For investigation of the molecular basis of communication between these entities and the roles of the involved proteases, growth factors or cytokines, the models of choice are genetic loss or gain of function mice. They allow for modulation of tissue homeostasis of the three compartments. In this context, special interest should be focused on extracellular proteases, as their complex systems biology is now increasingly recognized as an important determinant of tissue homeostasis, and is also involved in cancer (auf dem Keller et al., 2007) . Therefore, functional genetic studies, aiming at interference with the biology of proteases, are suitable examples to examine the possibilities and limitations of current mouse models.
This brief review will focus on functional genetic studies of the tumor-associated matrix metalloproteinases (MMPs) and their inhibition and will address some new information about local organ-specific proteolytic networks, which can communicate over a distance and affect the metastatic potential of tumor cells.
Proteases regulate organ homeostasis
Proteases are the essential players in organ homeostasis: they do not only exhibit their degradative role in the turnover of the extracellular matrix during development, tissue regeneration and maintenance, but are recently appreciated as specific modulators of signaling molecules and their underlying pathways (auf dem Keller et al., 2007) . Their important and complex regulatory functions are also reflected by the fact that proteases represent the largest enzyme family in man (1.7% of human genes), second only to transcription factors in family size (Puente et al., 2003) . Furthermore, the proteases and their natural inhibitors form cascades, regulatory circuits, and networks that dynamically interconnect in the socalled 'protease web' (Overall and Kleifeld, 2006) . Consequently, in the past years 'degradomic' studies have been initiated aiming to elucidate the specific role of individual proteases as well as their involvement in higher orders of complexity (Overall and Kleifeld, 2006) . The initial results derived from these studies promise to lead protease research into a new era: the systems biology of proteases (auf dem Keller et al., 2007) . These theoretical considerations now require us to still take many experimental steps in order to understand the biology of proteases and, as a consequence, the biology of organ homeostasis in normal and pathophysiological conditions. This is even more important, as in research on yet incurable diseases, including cancer, there is still hope to develop new therapies which consider the complexity of biological systems and would therefore be more efficient in avoiding severe side effects.
When trials turn bad: lessons from non-specific interference with proteolytic networks
Unspecific interference with the proteolytic network was employed during the pharmaceutical development of matrix metalloproteinase inhibitors (MMPIs). MMPs are a group of more than 20 Zn-dependent proteolytic enzymes that can degrade the main components of the extracellular matrix and the basement membrane to various degrees (Brinckerhoff and Matrisian, 2002) . Therefore, MMPs were generally considered as the central players during invasion and metastasis of cancer cells. The concept at the time was that broad-spectrum inhibition should block tumor cell spread by decreasing their invasive potential (Wojtowicz-Praga et al., 1997) . In view of the new line of protease research explained above, it is, in hindsight, not surprising that introduction of MMPIs into the clinic as anti-cancer drugs has failed (Coussens et al., 2002) . Considering the misled expectations on the options and limitations of the mouse models used during the pre-clinical phase of MMPI development (reviewed in Kopitz and Krü ger, 2008) , it is now clear that without the better knowledge of the protease web a rational approach was impossible. DeClerck et al. (1997) had summarized and pointed out, already two years before the termination of the first clinical phase III cancer trials with MMPIs, the evidence for the complex interactions that exist among proteases.
In the aftermath of the disappointment and in the wake of finding possible explanations for the failure of these trials, it was shown that broad-spectrum inhibition of MMPs alters the liver physiology in a way that it attracts more metastases (Krü ger et al., 2001 ). More recently, by a functional genetic approach, the mechanism of the increased susceptibility of the liver to metastases was found: broad-spectrum inhibition of MMPs induces the cMet-signaling pathway in the liver which triggers a cascade known to promote the scattering of tumor cells (Kopitz et al., 2007) . Even newly developed and highly selective MMPIs (Fisher and Mobashery, 2006) seem to be not suitable to distinguish the in vivo role of the two enzymatically very similar gelatinase-type MMPs-2 and -9, only functional knockdown of MMP-2 or MMP-9 in tumor cells can reveal the distinct functions of these molecules during metastasis (Gerg et al., 2008) . These latter examples show that functional genetic approaches give us a deeper insight into the biology of protease activity as well as its inhibition.
The potential of specific protease-deficient mouse models
As explained above, analysis of the role of particular MMPs during metastasis requires maximum selectivity. Current state-of-the-art to specifically suppress the activity of single genes is modulation of their gene expression by knockout or knockdown. When knockout mice are generated, we can learn about the role of this gene in the host tissue during embryogenesis and development as well as in its response to disease challenges imposed by transplantation of pathogens or tumor cells or by crossing with genetically engineered disease models (e.g., tumor models as reviewed by Frese and Tuvesan, 2007) .
Regarding interference with proteolytic networks and homeostasis, it is very important to point out two principally distinct types of knockout mice: the first group showing an overt lethal or disease phenotype. In this case, one can conclude that the missing gene has a rather direct function in the affected physiology and no compensation by other genes had occurred. According to the 14th-century philosophical principle known as Occam's razor -that the simplest explanation for a phenomenon is likely the truth -this group serves well in the definition of drug targets (Bolon and Galbreath, 2002) . The second group is represented by surviving mice with an obviously healthy phenotype, which means that the missing gene was compensated and a new homeostasis had been established. In respect to the definition of potential therapeutic targets and molecules, these latter mice are of less interest and could actually serve to prune irrelevant molecules and targets (Bolon and Galbreath, 2002) . This notion should be even more considered with regard to the target-finding endeavors in functional protease research, as especially in many of the protease-deficient mice the overt phenotypes are subtle or absent.
It is important, however, to realize the experimental potential of such models. Although the re-adapted homeostasis upon gene ablation might not be evident at first sight, it may well have an impact on disease challenges and elucidate increased or decreased susceptibility of microenvironments and the role of the ablated gene. With both groups of knockout mice, excellent models are in our hands to probe for the complexity of the proteolytic web in living organisms in different situations. With this in mind, the following sections will examine and appraise some of the sometimes conflicting results published about MMP knockout mice regarding their susceptibility to tumors.
Results from MMP ablation according to the dogma
The general assumption was that MMPs are essentially tumor-promoting molecules and excellent drug targets (Wojtowicz-Praga et al., 1997) , and there are a number of reports with MMP-deficient mice that are still in line with this original dogma showing that MMPs can be important cofactors in the development of tumors: for example, MMP-7 is involved in the development of intestinal adenomas in the multiple intestinal neoplasia mouse model (Wilson et al., 1997) . Implantation of melanoma and Lewis lung carcinoma cells into MMP-2-deficient mice reduced angiogenesis and tumor progression (Itoh et al., 1998) , and MMP-9-deficiency suppressed experimental lung metastasis (Itoh et al., 1999) . MMP-11 seems to be involved in the promotion of dimethylbenz-anthracene-induced carcinomas, as tumor incidence and size was reduced in MMP-11-deficient mice (Masson et al., 1998) . In the K14-HPV16 multistage skin carcinogenesis model, genetic elimination of MMP-9 reduced the incidence of carcinomas (Coussens et al., 2000) . Similar tumor-promoting activity of host-derived MMP-9 was found in pancreatic islet carcinogenesis (Bergers et al., 2000) .
Gender-, mouse strain-, and organ site-specific effects of MMP ablation
The critical appraisal of the failures of the clinical trials with MMPIs opened the gate for a series of publications which were against the original dogma and showed that elimination of individual MMPs can even have promoting effects on tumors and metastasis. Balbín et al. (2003) showed that genetic ablation of MMP-8 increased the susceptibility to skin tumors in male mice, an effect which is based on the function of MMP-8 in the immune system. Interestingly, this first identification of a protective function of a specific MMP in cancer was gender-specific. It could be reproduced in female mice when they were treated with tamoxifen or ovarectomized. In this context, it is important to note that female sex hormones play a significant role in altered homeostasis of the protease web.
Recently, Martin et al. (2008) showed that the genetic background of mice can determine whether or not MMP-9 is involved in the promotion of spontaneous lung metastasis in the multistage mammary tumor model MMTV-PyVT. While crossing-in MMP-9-deficient mice of the C57BL/6 background into the MMTV-PyVT model led to 80% decreased lung tumor burden, MMP-9-deficient mice of the FVB/N background did not show any differences compared to respective MMP-9-positive controls. The authors conclude that the function of MMP-9 during tumor progression is highly influenced by genetic factors, and the genetic background determines whether or not MMP-9 inhibition is beneficial or not. What this clearly shows is that interference with the proteolytic network by ablation of MMP-9 induces a re-adaptation of the entire homeostasis of the mouse model by involvement of other genetic factors. In other words, the strain-specific transcriptome interacts differently with the changes in the proteolytic network, and the differentially altered protease web determines the susceptibility to disease. Such strain-specific phenomena had already been discussed previously with regard to other disease models (Schauwecker, 2002 ).
An organ-specific effect was found when MMP-7 was ablated in mice: while MMP-7-deficiency suppressed the formation of benign intestinal adenomas (Wilson et al., 1997) , a more recent study showed that the number of experimental lung metastases is increased in MMP-7-deficient mice compared to the wild-type control (Acuff et al., 2006) . This phenomenon was not discussed in more detail in that study but attributed to a possible tumor-protective role of MMP-7 in the lung. Clearly, these data are, together with the observation by Wilson et al. (1997) , in line with the emerging appreciation of the protease web and add an important aspect to it: depending on the organ site, MMPs play different roles in the maintenance of homeostasis. Obviously, different organs (intestine, lung), even when the genetic background of the mice is the same, exhibit different transcriptomes; in other words, they have distinct molecular phenotypes which determine the homeostasis of each organ. Hence, lack of MMP-7 interferes with the homeostasis in the intestine so that adenoma formation is suppressed, while absence of MMP-7 induces a re-adaptation of the lung tissue with the consequence that it becomes more susceptible for metastases.
Site-specific induction of gene expression changes upon interference with the proteolytic network
Each of the examples given above indicate that these functional genetic models show the interrelation between the proteolytic network and the respective molecular phenotype at different levels of a living organism, namely gender, individuality (mouse strains), and organ differentiation. Transcriptome analysis by low-density array technology on large scale is nowadays a straightforward approach in order to characterize the molecular phenotype (Goulter et al., 2006) . Some of the conflicting results obtained with regard to interference with proteases could be explained if the 'ripples through the protease web' (Overall and Kleifeld, 2006) would be analyzed by such methods. We have to keep in mind that knockout of homeostasis-determining molecules, such as proteases, can alter the entire gene expression profile and, therefore, provide new microenvironments with sometimes unforeseeable effects regarding disease susceptibility. In addition, comparison of gene expression profiles before and after knockout of a gene will enable us to understand, on the level of systems biology, the far-reaching roles that proteases play in local (organ-specific) and global (entire-living organism) homeostasis.
In a pilot study, we (Gerg et al., unpublished ) observed a dramatic MMP-9 deficiency-induced adaptation of the mRNA expression signature of metastasis-associated genes in the liver, one of the most afflicted organs of metastasis ( Figure 1A) . The knockout of a protease may not only affect regional proteolytic networks, as evident from the tumor-inhibiting but metastasis-promoting effects of MMP-7 (Wilson et al., 1997; Acuff et al., 2006) , but also somehow interferes with the communication between different regional networks, as can be deduced from the sex hormone-dependent effects in MMP-8 knockout mice (Balbín et al., 2003) . In MMP-9-ablated mice, the strong induction ()5-fold) of a cytokine, interleukin-6 (IL-6), compared to wild-type control was therefore especially interesting, even more so as immunohistochemistry revealed that IL-6 was mainly overexpressed in hematopoietic cells localized in the liver vascular system (data not shown). Indeed, IL-6 expressing cells could be removed from the liver by perfusion, indicating circulating hematopoietic cells as a source ( Figure 1B) . Analysis of IL-6 expression in the bone mar- row showed a drastic upregulation in MMP-9-deficient mice compared to the control ( Figure 1C ). This drastic induction of IL-6 expression in hematopoietic cells was also associated with significantly elevated levels of this cytokine in serum ( Figure 1D ). In MMP-8-deficient mice, sex hormones could suppress the susceptibility of the skin to chemically induced tumor formation (Balbín et al., 2003) , a scenario where signaling molecules from the ovaries acted over a distance on the local proteolytic network in the skin. With this in mind, we were interested to see whether the changes in the local proteolytic network of the bone marrow, leading to upregulation and secretion of IL-6 into the circulation, might also have an effect on a disease-challenge. Elevated levels of IL-6 in the serum are a negative prognostic marker for survival of colorectal cancer patients (Clinchy et al., 2007) . Therefore, we challenged MMP-9-deficient and wild-type control mice with lacZ-tagged murine colorectal carcinoma cells (CT26-lacZ). These cells normally form macrometastases in lung and only very few cells can be detected in the liver by X-gal staining. In the MMP-9-deficient microenvironment, a drastic 8-fold induction of invasion of CT26-lacZ cells, compared to the control, was observed ( Figure 1E ). Formation of CT26-lacZ metastases in the lung was not affected (data not shown), similar to the results described with the same FVB/N genetic background (Martin et al., 2008) . Increased proteolysisdependent invasion of CT26-lacZ cells due to IL-6 ( Figure  1F) indicates that MMP-9 ablation-induced changes in the local proteolytic network in the bone marrow can act, via IL-6, on the proteolytic network of tumor cells. These data suggest that protease-deficient models combined with gene expression analysis will allow elucidation of the complex changes in the protease web. In addition, this example and the work of Balbín et al. (2003) show that local proteolytic networks can effectively communicate with each other via signaling molecules, such as hormones or cytokines.
Figure 2
The proteolytic internet. The proteolytic internet is formed by a network of regional proteolytic networks, interconnected via the circulation as the information highway. Cytokines or hormones are the transmitted data packages. The regional proteolytic networks are specific for defined organ compartments, such as the bone marrow, endocrine glands, sites of primary tumorigenesis, sites of metastasis, circulating tumor or immune cells, etc. Each proteolytic network interacts with underlying cell signaling events ('protease web'). If hormone or cytokine secretion is regulated by the regional homeostasis, changes of homeostasis by protease ablation will be transmitted via the circulation, affecting homeostasis and the regional proteolytic network at a distant site.
The proteolytic internet
The internet in information technology is defined as the collection of inter-connected regional networks, where data are transmitted by an information superhighway (Tanenbaum, 1996) . The data summarized here suggest that a proteolytic internet exists (Figure 2 ). Especially regarding tumor progression and metastasis there is strong evidence for regional (organ-or even tissue-specific) proteolytic networks which control organ-specific homeostasis through its signaling function in underlying signaling events (composing the 'protease web'). There is also increasing evidence that regional proteolytic networks can communicate with each other over a distance via the circulation as the superhighway of data transmission by hormones or cytokines. The concept of endocrine communication is well established in internal medicine and describes the secretion of information (hormones) by specific glandular tissues. It is a new concept, however, that non-glandular tissues may also be able to communicate their status (maintained by the regional proteolytic network) over a distance and can have an impact on other tissues or circulating tumor cells, etc.
The given examples show the significance of local proteolytic networks for tumorigenesis or metastasis. It is also evident that a knockout mouse consists of at least as many molecularly different compartments as it has differentiated tissues. The determining feature of differentiation is the gene expression profile, and each tissue reacts differently to the ablation of a homeostasis-governing protease gene. Proteases are key molecules in controlling homeostasis in an organ. This also means that if one protease of a local network is inhibited, other proteases and their underlying signaling cascades will restore a new dynamic equilibrium, allowing the development or maintenance of a fully functional organ.
The local proteolytic networks can communicate their status over a distance when a protease-controlled cascade affects the secretion of signaling molecules, such as hormones or cytokines. When these signaling molecules directly interact with a disease-challenge, such as circulating tumor cells, proteolytic changes in one organ, for example, in the bone marrow, may be sufficient to render metastasis to another site by increasing the metastatic potential of tumor cells.
Evidently, the proteolytic internet serves as an important regulatory device to develop, maintain, and adapt the tissues of an entire organism at different intrinsic physiological or environmental changes, and it is one entity where systems biology can be observed in action. Possibly, the proteolytic internet may even be active during the communication between the different germ layers during development.
Conclusions
The great potential of functional genetic models with ablated expression of individual proteases lies in the characterization of organ-, gender-, mouse strain-specific, and also spatio-temporal molecular cascades, if gene expression profiles are analyzed. Such an approach belongs to the field of systems biology and will reveal insights where more conventional attempts with functional genetic mouse models are reaching their limits. Hence, we should reappraise Shapiro's expectation that with transgenic and knockout models we are finally in 'an era where controlled experiments can be performed in complex mammalian models' (Shapiro, 1997) . This statement is valid as long as functional genetic mouse models are viewed with more care: if a gene (of MMPs, other proteinases or any other regulatory molecule) is ablated in a living organism, and obvious functional or structural phenotypes are lacking, its role can be described in the complex network where it is embedded, including gender-and strain-related polymorphism of the mice used.
As exemplified here with the experiences in the protease field, it seems generally necessary to very carefully examine the implications of the multitude of crossing experiments which are performed with genetically engineered mice. This notion is extremely important in the course of new drug target selection and the development of new therapeutic strategies (Bolon and Galbreath, 2002) . Intriguingly, pharmacological inhibitors of MMP-9 show different efficacy depending on the mouse-strain used (Martin et al., 2008) . In addition, we also found that ablation of members of other protease families can lead to unexpected outcomes with regard to disease challenge: total ablation of the cysteine protease cathepsin B (CTSB) leads to yet molecularly undefined redistribution of cathepsin X at the cell surface, which led to a slight compensation of the metastatic potential of tumor cells compared to tumor cells heterozygous for ctsb (Vasiljeva et al., 2006) .
Further studies are currently underway characterizing the proteolytic internet in more detail. For example, we are investigating the molecular nature of the local protease network in the MMP-9-deficient bone marrow and whether the resulting cytokine signal has an impact on tumor cells with different origin. Finally, it is possible that a set of signal molecules mediating the information exchange in the proteolytic internet can promote identification of diagnostic markers for personalized health care of protease-associated diseases.
